Cision PR Newswire

AccidentAccidentAir PollutionAll NewsAnnoucementArgricultureArtASEANBook

Cognizant dedicates more than 25,000 professionals to Claude delivery, introduces managed services model to run Claude at the core of enterprise operations

Cognizant's new Claude Frontier Capability Group brings more than 25,000 professionals together in a dedicated global Claude delivery organization. Cognizant's...

Zepp Health Corporation to Report Third Quarter 2026 Financial Results on November 22, 2026

Earnings Call Scheduled for 8:30 p.m. ET on November 22, 2026 MILPITAS, Calif., Nov. 10, 2026 /PRNewswire/...
Cision PR Newswire

Towards Buddha Leads Taiwan TPU Alliance to Showcase One-Stop Medical TPU Solutions at COMPAMED 2026

Alliance initiated by Towards Buddha brings together specialized industry partners across Taiwan's medical TPU...
Cision PR Newswire

Momcozy Expands U.S. Retail Footprint With Sam’s Club and BJ’s Wholesale Club

NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Momcozy, a global maternal and baby care...
Cision PR Newswire

KPJ Healthcare Leads ASEAN in Healthcare Brand Strength, Ranks Second in Brand Value

Valuation rises 45% to USD305 million as Group advances 49 places in Brand Finance...
Cision PR Newswire

JoyLogistics Launches Integrated Delivery and Installation Service for Bulky Items in Malaysia and Singapore

SINGAPORE, Oct. 31, 2025 /PRNewswire/ -- JoyLogistics, the supply chain solutions arm of JINGDONG Logistics (JD Logistics), announced the launch of its integrated delivery...

Abu Dhabi Royal Equestrian Arts, the World’s Fifth School of Classical Horsemanship, Officially Opens Its Doors

ABU...

NAVEE Launches XT5 Pro All-Terrain Electric Scooter, Expanding Green Mobility Beyond the City

EL MONTE, Calif., Oct. 31, 2025 /PRNewswire/ -- NAVEE, a leading innovator in smart mobility, today unveils the XT5 Pro All-Terrain Electric Scooter, designed...

Zhimeng Biopharma’s investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.

SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment...

NYSE Content Advisory: Pre-Market Update + Emera Celebrates NYSE Listing

NEW...

BingX Bridges TradFi and Web3 at Blockchain Life 2025, Celebrates Top Industry Recognition

PANAMA...
1...2,2142,2152,216...4,518Page 2,215 of 4,518